NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)
Viramune is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in people at least 15 days old. Viramune is recommended in combination with other antiretroviral medications. Viramune is also referred to by its drug name, Nevirapine, and by the abbreviation NVP.
Viramune is an antiviral medication of the non-nucleoside reverse transcriptase inhibitor (NNRTI) class. Viramune is believed to work by preventing HIV from replicating in cells.
How do I take it?
Prescribing information states that Viramune is taken once or twice a day.
Viramune comes in tablet or oral suspension forms.
The FDA-approved label for Viramune lists common side effects including vomiting, nausea, diarrhea, fatigue, headache, stomach or muscle pain, and changes in the shape or location of body fat.
Rare but serious side effects listed for Viramune include severe skin reactions and liver failure.
For more details about this treatment, visit:
Viramune – RxList
Overview of HIV Treatments – AIDS.gov